Binx IO Point-of-Care Test for Chlamydia trachomatis and Neisseria gonorrhoeae Infections

Binx IO is a cartridge-based test with a Clinical Laboratory Improvement Amendment (CLIA) waiver that detects Chlamydia trachomatis and Neisseria gonorrhoeae infections in patients with or without symptoms.1 The molecular assay is performed by clinicians using vaginal swabs or male urine specimens....

Full description

Saved in:
Bibliographic Details
Published inAmerican family physician Vol. 106; no. 5; pp. 575 - 577
Main Authors Clebak, Karl T, Bensur, Justine, Sell, Jarrett K
Format Journal Article
LanguageEnglish
Published United States American Academy of Family Physicians 01.11.2022
Subjects
Antibiotics
Asymptomatic
Chlamydia
Chlamydia Infections - diagnosis
Chlamydia trachomatis
Condoms
Gonorrhea
Gonorrhea - diagnosis
Humans
Infections
Medicaid
Medical laboratories
Medicare
Neisseria gonorrhoeae
Point-of-Care Testing
Sexually transmitted diseases
STD
Urine
Vagina
Women
Online AccessGet full text

Cover

More Information
Summary:Binx IO is a cartridge-based test with a Clinical Laboratory Improvement Amendment (CLIA) waiver that detects Chlamydia trachomatis and Neisseria gonorrhoeae infections in patients with or without symptoms.1 The molecular assay is performed by clinicians using vaginal swabs or male urine specimens. Results are available in 30 minutes, allowing for testing and treatment in a single visit.1
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0002-838X
1532-0650